Global Ocular Inflammation Treatment Market (2019-2023) is Expected to Grow at a CAGR of More Than 6% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Global Ocular Inflammation Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.
The ocular inflammation treatment market will register a CAGR of more than 6% by 2023.
The technological advances in drug delivery to push growth in the market. The increasing need for novel drug delivery systems has led to the advent of intravitreal implants, which are small hair-stranded sized devices that are implanted into the middle layer of the eye.
Growing awareness of eye care
Several organizations are conducting awareness campaigns on various eye-related diseases. Thus, the rising awareness about eye related diseases, including ocular inflammation is expected to contribute to the market growth during the forecast period.
Growing preference for surgeries
The global ocular inflammation market poses high threat from alternative treatment options such as non-invasive surgeries such as LASER treatments and invasive surgeries such as vitrectomy.
Key PlayersAbbVie Allergan Bausch Health Novartis Pfizer
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPEMarket ecosystem Market characteristics Market segmentation analysis
PART 04: MARKET SIZINGMarket definition Market sizing 2018 Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCTMarket segmentation by product Comparison by product Corticosteroids - Market size and forecast 2018-2023 Immunosuppressants - Market size and forecast 2018-2023 Anti-infectives - Market size and forecast 2018-2023 Other drug classes - Market size and forecast 2018-2023 Market opportunity by product
PART 07: MARKET SEGMENTATION BY ROA
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPEGeographic segmentation Geographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPEOverview Landscape disruption
PART 14: VENDOR ANALYSISVendors covered Vendor classification Market positioning of vendors AbbVie Allergan Bausch Health Novartis Pfizer
For more information about this report visit https://www.researchandmarkets.com/research/tgz8nr/global_ocular?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005706/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Optical ,Optical Disorders Drugs
INDUSTRY KEYWORD: HEALTH OPTICAL PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/19/2018 02:21 PM/DISC: 12/19/2018 02:21 PM